
Emquin 64.5mg Injection
Marketer
Merck Ltd
Salt Composition
Chloroquine (64.5mg)
Overview Emquin 64.5mg Injection
Malarone 64.5mg Injection, an antimalarial drug, prevents and treats malaria by eliminating the parasitic infection and halting its spread. This injection must be administered solely by a qualified healthcare provider; self-administration is strictly prohibited. Mosquito bite prevention is crucial; apply insect repellent to exposed skin, spray repellents indoors, and wear light-colored, protective clothing after dusk. Potential side effects include weakness, nausea, vomiting, rash, itching, abdominal discomfort, diarrhea, and decreased appetite. Injection site reactions (pain, swelling, redness) may also occur. Prolonged side effects warrant immediate medical consultation. Diabetic patients should inform their doctor, as this medication can lower blood glucose levels, necessitating regular blood sugar monitoring. Blurred vision is possible, prompting the need for routine eye exams during treatment. Long-term use may necessitate regular blood cell count monitoring. Report any unexplained bleeding or bruising, sore throat, fever, or persistent fatigue to your physician.
Uses of Emquin 64.5mg Injection
Managing Malaria Infections
Major Benefits of Emquin 64.5mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Emquin 64.5mg Injection:
- Weakness
- Rash
- Headache
- Dizziness
- Vomiting
- Nausea
- Stomach pain
- Loss of appetite
- Diarrhea
How to use Emquin 64.5mg Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
How Emquin 64.5mg Injection works:
Malaria is effectively combated by the antiparasitic drug Emquin 64.5mg Injection. Its mechanism involves elevating blood heme concentrations, a process lethal to the malaria parasite, thereby eliminating the infection.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Emquin 64.5mg Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Emquin 64.5mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactating individuals may safely administer Emquin 64.5mg Injection. Research in humans indicates negligible transfer of the medication into breast milk, posing no identified risk to the infant.
DrivingUNSAFE
Administering Emquin 64.5mg Injection may induce adverse reactions that impair driving capabilities. These reactions can include blurry vision or difficulty focusing, potentially affecting the ability to operate a vehicle safely.
KidneyCAUTION
For individuals with kidney impairment, administration of a 64.5mg Emquin injection requires careful consideration. Dosage modification of the 64.5mg Emquin injection might be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when administering the 64.5mg Emquin injection. Dosage modification of the 64.5mg Emquin injection might be necessary. Physician consultation is recommended. Routine liver function assessments may be prudent during treatment.
What if you forget to take Emquin 64.5mg Injection :
NA
Facts to Know About Emquin 64.5mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoquinoline derivative (4-substituted) |
| Developing Good Habits | No. |
| Treatment Category | Ophthalmology |
| Actions | Aminoquinoline Antimalarials |
